NCT03166124View on ClinicalTrials.gov

A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

November 18, 2017

Study Completion Date

November 18, 2017

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

Trial Locations (2)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Mainz

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri, 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST) or speak with your personal physician., Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03166124 - A Study of LY900014 in Elderly and Younger Adult Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter